Eliminating Drug Rebates: Bad for Seniors and Taxpayers, Good for Big Pharma

Rebate Rule Raises Seniors’ Medicare Premiums to Pay for Pharmaceutical Industry Windfall

Washington, D.C., November 20, 2020 – Today, the Coalition for Affordable Prescription Drugs released the following statement regarding the Trump…

Economist Alex Brill in Q&A With Carol Vassar on Drug Companies’ Anticompetitive Behavior

On October 1, Matrix Global Advisors’ CEO Alex Brill joined POLITICO health care contributor and podcast host Carol…

The Coalition for Affordable Prescription Drugs (CAPD) represents a diverse group of public and private employers, retirees, unions and the pharmacy benefit mangers (PBMs) they partner with to provide affordable, sustainable prescription drug coverage to their employees and members.

Latest Updates

New Report Quantifies the Harm of Product Hopping to Patients and the U.S. Health Care System

New Data: American Seniors and Voters are Very Concerned About the Prospect of No Rebates & Higher Costs in Medicare Part D

Tweets by RxDrugCoalition

Fast Facts

CAPD
Policy

A common-sense policy agenda to lower drug prices

PBM
Value

Why employers partner with PBMs to effectively manage their prescription drug benefits

CAPD in the states

Information on CAPD’s activity in Texas, New York, Pennsylvania, Illinois and Georgia